WSA maintains guidance despite strong growth – CEO explains why
A stringent focus on prices and costs has helped WS Audiology book a revenue growth of 20% despite global supply issues and increasing inflation, CEO Eric Bernard tells MedWatch.
by andreas lønstrup, translated by daniel pedersen
WS Audiology is well on the way to solidifying the financial year of 2021/2022 as a great one for the hearing aid manufacturer.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
WS Audiology's revenue grew by 20% in Q2 2021/2022
For subscribers
GN Hearing lets staff go to optimize supply chain
For subscribers
CEO of WSA: "Multi channel is the future"
For subscribers
.jpg&w=384&q=75)
